Transcranial magnetic stimulation (TMS) is a drug-free, non-invasive therapy. TMS treatment uses magnetic pulses to stimulate electrical activity in the brain’s neurons (nerve cells). TMS is also referred to as repetitive TMS (rTMS), because treatment typically includes the delivery of repetitive magnetic pulses. TMS has been cleared by the FDA for use in treating a limited number of conditions, including Major Depressive Disorder, Obsessive-Compulsive Disorder, and pain associated with certain migraine headaches.
Personalized repetitive Transcranial Magnetic Stimulation (PrTMS®) is TMS — but with a smarter, more sophisticated approach. Unlike conventional TMS that is one-size-fits-all, PrTMS® intricately customizes the TMS therapy delivered to each patient – which may help patients achieve optimal results.
PrTMS® uses brainwave analysis to measure brain activity and develop a customized therapy protocol for each patient’s unique brain mapping that is verified and approved by a qualified PrTMS® provider – this helps ensure patients receive optimized treatment.
PrTMS® involves a 3-step process that includes evaluation of your brain function, creation of a personalized and provider-reviewed and verified treatment plan, and application of the TMS therapy using the treatment plan.
No. PrTMS® is a method of developing personalized treatment protocols for use with rTMS therapy, and is provided as part of a physician’s practice of medicine and in accordance with his or her medical judgment. PrTMS® is not a product and has not been evaluated by the FDA.
Common side effects may include headache, scalp discomfort at the site of stimulation and lightheadedness. If there are side effects, they are generally mild and to moderate and improve shortly after an individual session and decrease over time with additional sessions. In addition, hypoglycemia has been noted in some patients. Serious side effects, though uncommon, also may occur.
No. Patients with aneurysm clips, stents in the neck or brain, brain monitoring electrodes, deep brain stimulators, or any form of metal in the head or on the face are not eligible for treatment. Patients with a history of bipolar disorder, schizotypal disorder, seizure disorder, or who have been prescribed anti-psychotic medications in the past should generally not undergo treatment.
The first step of PrTMS® is to evaluate and map your brain function. An EEG recording will be taken to measure your brain activity. The EEG device is wireless, involves no gels, and can take a recording in less than 5 minutes – compared to conventional methods, which can require several hours. This provides an objective, quantitative look at brain function
In addition to the EEG, you will be given a patient neurocognitive questionnaire. Your responses provide subjective, qualitative inputs that — along with the EEG data — form a complete picture of your brain health.
An initial treatment plan consists of treatment 5 days a week, for a period of 4 to 6 weeks. After the initial treatment period, maintenance sessions can be scheduled according to how you feel and your doctor’s clinical judgment.
Your brain function will be measured weekly and the treatment plan will be modified based on the data collected. The total number of treatments varies from patient to patient. An initial treatment plan typically consists of 20 to 30 sessions. Frequency of maintenance sessions depends on your unique circumstances.
Diagnostic testing is generally done every 5 treatments, or about once per week. The ongoing diagnostic testing adds very little time to your appointment and is crucial to ensure that you are receiving the best treatment possible.